Know when retatrutide is approved.
Free email updates on trial results, FDA status and how to join a trial.
Get one email when the FDA decides.
We'll email you when there's an official FDA decision on retatrutide.
Independent educational digest. No dosing guidance, no marketing, no spam.
What's true today
Not FDA-approved yet
Retatrutide is an investigational drug from Eli Lilly and is not approved by the FDA for any use.
Phase 3 trials ongoing
Late-stage trials are currently running at sites around the world.
Only legal access is a trial
Retatrutide cannot be prescribed or legally bought today. Joining a trial is the only lawful route.
How to join a trial
Trials list where they are recruiting. Here is how to find one.
- 01
Search for open trials
Look up retatrutide on ClinicalTrials.gov to see which sites are recruiting near you.
Search ClinicalTrials.gov - 02
Check the eligibility rules
Each trial lists who can join, including age, BMI and health history.
- 03
Contact the study team
Use the contact details on the trial page to ask about screening.
Status timeline
- Early researchCompleted
- Early safety trialsCompleted
- Dose-finding trialsCompleted
- Phase 3 trialsIn progress
- FDA submissionUpcoming
- FDA decisionUpcoming